Abstract
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful skin ulcers with undermined borders and surrounding erythema. Cutaneous nocardiosis can present similarly, as ulcerative lesions, often following mechanical trauma, which is a shared risk factor for both conditions. In this case report, we describe an elderly patient on low-dose corticosteroids for polymyalgia rheumatica who developed rapidly progressive skin ulcers after sustaining a mechanical injury while gardening. The patient did not respond to broad-spectrum antibiotics. Histopathological examination of a skin biopsy revealed features consistent with PG, while culture of the same biopsy grew Nocardia abscessus. The patient was treated with a combination of high-dose corticosteroids, trimethoprim-sulfamethoxazole, and doxycycline, leading to complete clinical recovery with residual post-inflammatory hyperpigmentation.
This case underscores mechanical trauma as a shared risk factor for the development of both PG and cutaneous nocardiosis. We hypothesize that the patient developed PG through the pathergy phenomenon following the initial injury and concomitantly developed N. abscessus infection. Chronic low-dose corticosteroid therapy likely was an additional risk factor for the development of cutaneous nocardiosis. However, the intriguing question remains whether N. abscessus infection itself could act as a trigger for the development of PG.
Keywords: corticosteroid, gardening, immunosuppression, mechanical injury, nocardia abscessus, pyoderma gangrenosum, skin ulcer
Introduction
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful skin ulcers with undermined borders and surrounding erythema [1]. Diagnosis typically requires a biopsy, preferably obtained from the edge of the ulcer, along with exclusion of infectious causes. Treatment focus is on pain relief, infection prevention, and the promotion of skin regrowth [2]. The first-line treatment for PG involves the use of fast-acting immunomodulating drugs such as corticosteroids or cyclosporine [1-3]. Slower-acting biologics such as tumor necrosis factor-α and interleukin-1β have also been used for treatment of resistant forms of the disease [1-3].
Nocardiosis is an infectious disease caused by a Gram-positive bacillus belonging to the genus Nocardia spp. These aerobic bacteria are commonly found in soil, freshwater, and saltwater environments [4]. Nocardiosis is considered an opportunistic infection, with approximately one-third of cases occurring in immunocompromised individuals, including those with HIV, organ transplant recipients, and patients undergoing chemotherapy for malignancy [5]. The lungs, brain, and skin are the most frequently affected organs. Because nocardiosis is most commonly acquired through inhalation of Nocardia spp. organisms from the environment, pulmonary disease is the predominant clinical presentation. Cutaneous nocardiosis is acquired through mechanical trauma and can present in four distinct clinical forms: primary cutaneous nocardiosis, lymphocutaneous nocardiosis, cutaneous manifestations of disseminated nocardial infection, and mycetoma [6].
Mechanical injury to the skin may serve as an entry point for Nocardia spp. and often precedes the development of cutaneous forms of nocardiosis [5,6]. Notably, mechanical trauma is also the most common precipitating factor for PG [1-2], suggesting that these two conditions share a common risk factor. By reviewing the MEDLINE/PubMed database for articles published in English, we found no reports of the concomitant PG and Nocardia abscessus following a single injury.
Case presentation
We present the case of an 87-year-old White man referred for hospital admission from a dermatology clinic due to a painful, rapidly enlarging ulcerative lesion on his right forearm. The patient’s medical history included diet-controlled type 2 diabetes mellitus, hypertension, polymyalgia rheumatica on chronic low-dose prednisone, stage II chronic kidney disease, permanent atrial fibrillation, asymptomatic moderate calcific aortic stenosis, and obstructive sleep apnea. His medications included acetaminophen 1000 mg every six hours as needed for pain, apixaban 5 mg twice daily, losartan 100 mg daily, and prednisone 5 mg daily. He reported allergies to atorvastatin, rosuvastatin, and simvastatin. He quit smoking more than 30 years ago, consumed approximately four alcoholic drinks weekly, and denied illicit drug use. He had no recent travel outside Wisconsin, no pets, and no reported tick exposure.
Ten days prior to admission, the patient sustained a mechanical injury in his right forearm while gardening. Over the subsequent three days, the lesion enlarged, and he developed persistent serosanguineous drainage, expanding erythema, and mild localized tenderness as illustrated in Figure 1. He denied fever, chills, or systemic symptoms. Vital signs were normal at the initial visit. The patient presented to urgent care, where examination revealed a 3 cm erythematous lesion with sanguineous drainage and no fluctuance or abscess. Motor and sensory examinations were normal, with palpable pulses. He was discharged on cefadroxil 500 mg twice daily for 10 days for presumed cellulitis.
Figure 1. Initial evaluation of the right forearm lesion .
This image was obtained four days after the initial injury while gardening.
Two days later (five days before admission), the patient returned to urgent care with worsening erythema, swelling, and pain. Examination showed a violaceous, indurated lesion approximately 6 cm in diameter with an additional 4 cm of surrounding erythema. A 1 mm to 2 mm central superficial opening was present, with minimal sanguineous drainage (Figure 2).
Figure 2. Right forearm lesion .
The lesion demonstrates a superficial breakout of the skin associated with a violaceous and indurated area of approximately 6 cm in diameter, with an additional 4 cm of surrounding erythema. This lesion progressed while the patient was taking cefadroxil.
Point-of-care ultrasound demonstrated cobblestoning without fluid collection. Clindamycin was added to cover for empiric methicillin-resistant Staphylococcus aureus (MRSA) coverage, and a wound culture was obtained. Despite dual antibiotic therapy, his symptoms progressed, and the lesion had expanded to 10 cm × 7 cm, with purpuric discoloration and beefy granulation tissue. The X-rays of the right forearm ruled out fracture, foreign body, or osteomyelitis. The patient then went to the dermatology clinic for evaluation, at which point the lesion measured 12 cm × 6.5 cm (Figure 3).
Figure 3. Progression of the lesion .
The lesion in this picture measured 12 × 6.5 cm on the right forearm and was characterized by epidermal loss with exposed granulation tissue, sanguineous drainage, and a border of violaceous erythema. The lesion was worsening despite broad-spectrum antibacterial coverage with cefadroxil and clindamycin.
The epidermis had sloughed, revealing granulation tissue with sanguineous drainage and violaceous peripheral erythema. The affected area extended from the distal forearm to the upper biceps. Peripheral pulses and sensation were intact. Range of motion was preserved except for mild restrictions in the wrist and elbow. A punch biopsy was performed, and the patient was referred for hospital admission due to lesion progression and persistent pain despite antibiotics. Upon admission, the patient appeared nontoxic, alert, and hemodynamically stable. The cardiovascular exam revealed an irregularly irregular rhythm and a systolic murmur. The skin exam demonstrated a large ulcerated and pustular wound with sanguineous discharge and marked tenderness. Erythema and warmth extended proximally to the upper arm (Figure 4).
Figure 4. Right forearm lesion demonstrating a large ulcerated and pustular wound associated with erythema and warmth extended proximally.
General surgery was consulted, but found no evidence of necrotizing fasciitis or compartment syndrome. Given the rapid lesion progression, pain out of proportion to findings, and lack of response to antibacterial antibiotics, PG was suspected. Prednisone was increased from a baseline of 5 mg daily to 60 mg daily. Within 48 hours of the administration of steroids, the lesion began to regress, supporting a diagnosis of PG. A skin biopsy showed superficial and deep dermal inflammation composed of lymphocytes and neutrophils with negative special stains for microorganisms, including acid-fast bacillus (AFB), periodic acid-Schiff (PAS), and Gram stain (Figure 5).
Figure 5. Skin biopsy.
The biopsy revealed superficial and deep dermal inflammation composed of lymphocytes and neutrophils with negative special stains for microorganisms (including AFB, PAS, and Gram stain).
AFB: Acid-fast bacillus, PAS: Periodic acid–Schiff
Tissue culture (tests performed at Mayo Clinic Medical Laboratories) later grew Nocardia spp., at which point antimicrobial therapy was started with doxycycline 100 mg twice daily and trimethoprim-sulfamethoxazole 800/160 mg daily. Once final culture results confirmed N. abscessus complex with sensitivities, the patient’s therapy was continued with doxycycline for three months, and prednisone was gradually tapered down to his baseline of 5 mg daily for polymyalgia rheumatica. At follow-up two weeks before completing antibiotics (10 weeks from initial presentation), the wound showed significant clinical improvement, although with significant residual hyperpigmentation (Figure 6).
Figure 6. Resolution of the right forearm lesion after 10 weeks of treatment with post-treatment pigmentation.
Since PG can be associated with inflammatory bowel disease, a colonoscopy was performed, as well as fecal calprotectin, which was normal. Malignancy evaluation, including CT of the chest, abdomen, and pelvis with IV contrast, was negative for any lesions. Prostate-specific antigen was within normal range. A comprehensive autoimmune workup was negative for autoimmune diseases associated with PG. Comprehensive laboratory testing is detailed in Table 1. Given the lesion’s rapid development, significant improvement with corticosteroids, and supportive histopathology, we concluded that the primary diagnosis is PG, likely triggered by mechanical trauma and N. abscessus. Alternatively, nocardiosis might be a superinfection on the background of PG.
Table 1. Comprehensive workup performed for differential diagnosis of cutaneous nocardiosis and PG.
ANCA: Antineutrophil cytoplasmic antibody, PG: Pyoderma gangrenosum
| Test | Result | Reference range |
| Hemoglobin | 12.3 g/dL | 12-14 d/dL |
| Platelet count | 240 × 10⁹/L | 150-300× 10⁹/L |
| Leukocytosis | 13.4 × 10⁹/L | 4-10 × 10⁹/L |
| C-reactive protein | 15.4 mg/L | <5 mg/dL |
| Erythrocyte sedimentation rate | 41 mm/h | <10 mm/h |
| Sodium | 135 mmol/L | 135-145 mmol/L |
| Potassium | 4.3 mmol/L | 3.6-5 mmol/L |
| Magnesium | 2.0 mg/dL | 1.8-2.4 md/dL |
| Bicarbonate | 27 mmol/L | 26-30mmol/L |
| Anion gap | 10 | <12 |
| Creatinine | 1.17 mg/dL | 0.5-1.2mf/dL |
| Glomerular filtration rate (estimated) | 61 mL/min/1.73 m² | >90ml/min |
| Aspartate aminotransferase | 18 U/L | 15-40 U/L |
| Alanine aminotransferase | 11 U/L | 15-40 U/L |
| Wound cultures/biopsy | N. abscessus | |
| Non-tuberculous mycobacterial cultures | Negative | |
| Sporothrix schenckii | Negative | |
| Herpes simplex virus swab | Negative | |
| Varicella-zoster virus swab | Negative | |
| Hepatitis A serology | Negative | |
| Hepatitis B antigen/antibody | Negative | |
| Hepatitis C antibody | Negative | |
| HIV test | Negative | |
| Syphilis rapid plasma reagin | Negative | |
| Borrelia burgdorferi PCR and antibodies | Negative | |
| Tularemia antibodies | Negative | |
| Anaplasma phagocytophilum | Negative | |
| Ehrlichia chaffeensis | Negative | |
| Antinuclear antibody screen | Negative | |
| Cytoplasmic antineutrophil cytoplasmic antibody (ANCA) | Negative | |
| Perinuclear ANCA | Negative | |
| Cyclic citrullinated peptide antibody | <15 U | Negative |
| Rheumatoid factor | <15 IU/mL | Negative |
| Myeloperoxidase antibody | <2 U | Negative |
| Proteinase 3 antibody | 0.8 U | Negative |
| Phospholipid antibody IgG | <9.4 GPL | Negative |
| Phospholipid antibody IgM | <9.4 MPL | Negative |
| Prostate-specific antigen | Normal | |
| Carcinoembryonic antigen | Normal | |
| Cancer antigen 19-9 | Normal | |
| Serum protein electrophoresis | Normal | |
| Urine protein electrophoresis | Normal | |
| CT chest/abdomen/pelvis with IV contrast | Negative for malignancy | |
| Brain MRI | Negative for malignancy |
Discussion
Our case is compelling and, to the best of our knowledge, represents the only reported instance of overlapping cutaneous N. abscessus infection and PG Cutaneous nocardiosis is typically acquired through direct inoculation via exposure to contaminated soil, while PG is frequently triggered by mechanical trauma, both of which were present in our patient. This overlap underscores the need to consider both infectious and autoinflammatory processes in complex cutaneous lesions, particularly in individuals with relevant risk exposures.
In addition to mechanical trauma, PG may be precipitated by infection; however, infection is not the underlying cause of the disease. Importantly, infectious etiologies must typically be excluded prior to establishing a diagnosis of PG. The condition is primarily driven by autoinflammatory and dysregulated immune mechanisms and aberrant neutrophil function [7]. A key feature of PG is pathergy, a phenomenon in which minor trauma, including infections or surgical procedures, triggers the development of characteristic ulcers. In this context, soft tissue infection may serve as a nonspecific trigger for PG in susceptible individuals. However, the resulting ulcers are not infectious in origin [7-9]. Differentiating PG triggered by infection from ulcers caused by primary infectious agents is critical, as the therapeutic approaches diverge significantly. Immunosuppressive therapy, the cornerstone of PG management, can exacerbate true infections and lead to adverse outcomes if the diagnosis is incorrect. As illustrated in our case, mechanical injury or infection with N. abscessus may have acted as a triggering event for the development of PG. In such scenarios, patients may require concurrent management with immunosuppressive agents to treat PG and appropriate antimicrobial therapy to address secondary bacterial superinfection of the lesion.
Given our patient’s possible immunosuppression from steroid therapy, environmental exposure to soil during gardening, and clinical presentation, multiple diagnoses were considered. Initially, given the presentation of a lesion with erythema, drainage, and tenderness with a history of diabetes and chronic steroid use, a primary skin and soft tissue infection appeared most likely. This diagnosis became less compelling as the patient had failed treatment with multiple trials of broad-spectrum antibiotics.
The minimal surrounding erythema and no streaking or pain in his fingers and hands, with otherwise normal function of the affected extremity, ruled out necrotizing fasciitis and compartment syndrome. Imaging of the right lower extremity ruled out osteomyelitis or foreign body. Calciphylaxis was a consideration; however, this was less likely given mild renal impairment and the absence of end-stage renal disease. This was further ruled out as histopathology did not reveal calcifications, thrombosis, or other findings that are consistent with calciphylaxis [10].
A comprehensive autoimmune workup was pursued in search of a cutaneous manifestation of autoimmune disease, as our patient had a history of polymyalgia rheumatica, but it was unrevealing. Colonoscopy was negative for inflammatory bowel disease as well as fecal calprotectin. A CT scan of the chest, abdomen, and pelvis with the use of IV contrast ruled out intrathoracic or intra-abdominal malignancy. Cutaneous tularemia was a consideration due to the possibility of acquiring it through tick bites in endemic areas; however, the workup was negative. Finally, the cultures of the skin biopsy led to the diagnosis of cutaneous nocardiosis and PG.
In this case, the patient had an additional risk factor for nocardiosis in the form of chronic prednisone therapy for polymyalgia rheumatica. Chronic corticosteroid therapy is a well-established risk factor for Nocardia infection. Substantial evidence from retrospective cohort and case-control studies demonstrates a strong association between systemic corticosteroid use and nocardiosis, particularly among patients treated for autoimmune, inflammatory, or neoplastic conditions [11,12]. The increased susceptibility to nocardiosis in patients receiving long-term corticosteroids is primarily attributed to corticosteroid-induced impairment of cell-mediated immunity. This includes functional suppression of macrophages and T lymphocytes, which play a central role in host defense against intracellular pathogens such as Nocardia spp. Corticosteroids downregulate the expression of proinflammatory cytokines and chemokines, inhibit antigen presentation, and attenuate the activation and effector functions of both macrophages and T cells [13]. In addition, chronic corticosteroid use can lead to CD4+ lymphopenia and reduced serum IgG levels, further compromising the immune system’s ability to control opportunistic infections [12,13].
Nocardiosis is a difficult infection to treat, with no established guidelines of treatment given its variable susceptibility patterns [14]. Skin disease and non-complicated pulmonary infection are treated with single antibiotic therapy, while more severe disease requires a multidrug therapy regimen. Sulfonamides such as trimethoprim-sulfamethoxazole (TMP-SMX) have been the cornerstone of therapy. Oxazolidinones such as linezolid or tedizolid are alternatives; however, myelosuppression may limit their prolonged use. Additional agents such as minocycline, fluoroquinolones, and amoxicillin-clavulanate are oral options that have shown activity against Nocardia spp. in vitro [1-6]. These could be considered as alternatives to TMP-SMX only when the initial clinical response is favorable. Multidrug regimens include TMP-SMX and the addition of third-generation cephalosporins (ceftriaxone, cefotaxime), imipenem, or amikacin [1-6]. Antibiotic therapy is adjusted based on antimicrobial susceptibility results. Length of treatment is usually two to six months for most cases, but extended regimens are required in disseminated disease and those with central nervous system involvement.
Conclusions
This case report highlights the coexistence of two rare clinical entities, both of which share mechanical trauma as a common risk factor. Additionally, environmental soil exposure represents a unique risk factor for nocardiosis. Clinicians should recognize that PG is often triggered by mechanical trauma through the pathergy phenomenon. As illustrated in this case, nocardiosis can develop concurrently at the site of injury. Alternatively, nocardiosis may have triggered PG, or, if not the primary cause, it could have exacerbated the lesion, making it more severe.
In clinical scenarios such as the one described here, a combination of immunosuppressive and antimicrobial therapy may be necessary to achieve favorable outcomes. Careful vigilance is essential when managing patients with ulcerative skin lesions, as immunosuppressive treatment for inflammatory conditions like PG can worsen underlying infections. Further studies are warranted to explore whether infections such as nocardiosis may serve as potential triggers for the development of PG.
Disclosures
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Igor Dumic, Reginald Cosiquien, Libardo Rueda Prada, Milena Cardozo
Acquisition, analysis, or interpretation of data: Igor Dumic, Ronin Joshua S. Cosiquien, Joshua Jagodzinski, Danielle Alejandra Vargas Cardozo, David Ladin, Andrea Boni, Milena Cardozo
Drafting of the manuscript: Igor Dumic, Ronin Joshua S. Cosiquien, Joshua Jagodzinski, Danielle Alejandra Vargas Cardozo, Reginald Cosiquien, David Ladin, Milena Cardozo
Critical review of the manuscript for important intellectual content: Igor Dumic, Andrea Boni, Libardo Rueda Prada, Milena Cardozo
Supervision: Igor Dumic, Libardo Rueda Prada, Milena Cardozo
References
- 1.Pyoderma gangrenosum. Maverakis E, Marzano AV, Le ST, et al. Nat Rev Dis Primers. 2020;6:81. doi: 10.1038/s41572-020-0213-x. [DOI] [PubMed] [Google Scholar]
- 2.Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Am J Clin Dermatol. 2022;23:615–634. doi: 10.1007/s40257-022-00699-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cutaneous nocardiosis: a great imitator. Ramos-E-Silva M, Lopes RS, Trope BM. Clin Dermatol. 2020;38:152–159. doi: 10.1016/j.clindermatol.2019.10.009. [DOI] [PubMed] [Google Scholar]
- 4.Nocardiosis: updates and clinical overview. Wilson JW. Mayo Clin Proc. 2012;87:403–407. doi: 10.1016/j.mayocp.2011.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.State-of-the-art review: modern approach to nocardiosis-diagnosis, management, and uncertainties. Yetmar ZA, Marty PK, Clement J, Miranda C, Wengenack NL, Beam E. Clin Infect Dis. 2025;80:0. doi: 10.1093/cid/ciae643. [DOI] [PubMed] [Google Scholar]
- 6.Primary lymphocutaneous Nocardia brasiliensis in an immunocompetent host: case report and literature review. Dumic I, Brown A, Magee K, et al. Medicina (Kaunas) 2022;58:488. doi: 10.3390/medicina58040488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Insights into the pathogenesis of pyoderma gangrenosum. Becker SL, Vague M, Ortega-Loayza AG. J Invest Dermatol. 2025;145:1305–1322. doi: 10.1016/j.jid.2024.09.023. [DOI] [PubMed] [Google Scholar]
- 8.Pyoderma gangrenosum and superimposed infection: a case report. Gavioli EM, Casias M, Ngo L. Adv Skin Wound Care. 2020;33:1–3. doi: 10.1097/01.ASW.0000661796.90753.f3. [DOI] [PubMed] [Google Scholar]
- 9.Clinical characteristics, treatment, and wound management of pyoderma gangrenosum: a case series. Wang F, Li L, Li W, Ni X, Pan Z, Ying L, Zhu M. PLoS One. 2025;20:0. doi: 10.1371/journal.pone.0326203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Histologic comparison of normal and diseased skin in patients with suspected calciphylaxis. Cheeley JT, Jagannathan G, Ellis CL, O'Neill WC. J Am Acad Dermatol. 2025;93:975–979. doi: 10.1016/j.jaad.2025.05.1404. [DOI] [PubMed] [Google Scholar]
- 11.Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society Workshop report. Cheng GS, Crothers K, Aliberti S, et al. Ann Am Thorac Soc. 2023;20:341–353. doi: 10.1513/AnnalsATS.202212-1019ST. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study. Soueges S, Bouiller K, Botelho-Nevers E, et al. J Infect. 2022;85:130–136. doi: 10.1016/j.jinf.2022.05.029. [DOI] [PubMed] [Google Scholar]
- 13.Steroid-induced secondary immune deficiency. Mustafa SS. Ann Allergy Asthma Immunol. 2023;130:713–717. doi: 10.1016/j.anai.2023.01.010. [DOI] [PubMed] [Google Scholar]
- 14.How do I manage nocardiosis? Margalit I, Lebeaux D, Tishler O, Goldberg E, Bishara J, Yahav D, Coussement J. Clin Microbiol Infect. 2021;27:550–558. doi: 10.1016/j.cmi.2020.12.019. [DOI] [PubMed] [Google Scholar]






